Viking Global Investors LP Celldex Therapeutics, Inc. Transaction History

Viking Global Investors LP

  • $25.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$20.5 - $37.33 $10.1 Million - $18.3 Million
491,207 Added 26.6%
2,337,854 $63 Million
Q1 2022

May 16, 2022
BUY
$27.64 - $39.32 $30.1 Million - $42.8 Million
1,088,766 Added 143.66%
1,846,647 $62.9 Million
Q4 2021

Feb 14, 2022
SELL
$35.68 - $56.27 $157,527 - $248,432
-4,415 Reduced 0.58%
757,881 $29.3 Million
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $22.1 Million - $42.7 Million
762,296 New
762,296 $41.2 Million

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.22B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email